Cargando…

Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid

Docosahexaenoic acid (C22:6n-3, DHA) is the precursor of specialized pro-resolving lipid mediators (SPMs), such as resolvin, protectin, and maresin families which have been considered therapeutic bioactive compounds for human health. Growing evidence indicates that DHA and SPMs are beneficial strate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beyer, María Paz, Videla, Luis A., Farías, Camila, Valenzuela, Rodrigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421104/ https://www.ncbi.nlm.nih.gov/pubmed/37571256 http://dx.doi.org/10.3390/nu15153317

Ejemplares similares

High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation
por: Weiss, Gisela Adrienne, et al.
Publicado: (2013)

N-3 Polyunsaturated Fatty Acids and Their Lipid Mediators as A Potential Immune–Nutritional Intervention: A Molecular and Clinical View in Hepatic Disease and Other Non-Communicable Illnesses
por: Herrera Vielma, Francisca, et al.
Publicado: (2021)

Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma
por: Kytikova, Oxana, et al.
Publicado: (2019)

Ratio of Pro-Resolving and Pro-Inflammatory Lipid Mediator Precursors as Potential Markers for Aggressive Periodontitis
por: Zein Elabdeen, Hager R., et al.
Publicado: (2013)

Fatty Acid Oxidation and Pro-Resolving Lipid Mediators Are Related to Male Infertility
por: Signorini, Cinzia, et al.
Publicado: (2022)

Docosahexaenoic and Arachidonic Acids as Neuroprotective Nutrients throughout the Life Cycle
por: Sambra, Verónica, et al.
Publicado: (2021)

Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis
por: Philippe, Réginald, et al.
Publicado: (2018)

The Role of Specialized Pro-Resolving Lipid Mediators in Inflammation-Induced Carcinogenesis
por: Torres, Wheeler, et al.
Publicado: (2023)

Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators
por: Perez-Hernandez, Javier, et al.
Publicado: (2021)

Specialized Pro-resolving Lipid Mediators and Resolution of Viral Diseases
por: Ferri, Giulia, et al.
Publicado: (2023)

Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin intervention
por: Dalli, Jesmond, et al.
Publicado: (2023)

Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
por: Chávez-Castillo, Mervin, et al.
Publicado: (2021)

Specialized pro-resolving lipid mediators in endodontics: a narrative review
por: Aubeux, Davy, et al.
Publicado: (2021)

Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function
por: Brennan, Eoin, et al.
Publicado: (2021)

Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases
por: Gila-Diaz, Andrea, et al.
Publicado: (2021)

Omega-3 Lipid Mediators: Modulation of the M1/M2 Macrophage Phenotype and Its Protective Role in Chronic Liver Diseases
por: Videla, Luis Alberto, et al.
Publicado: (2023)

Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis
por: Recchiuti, Antonio, et al.
Publicado: (2019)

Docosahexaenoic Acid Decreases Pro-Inflammatory Mediators in an In Vitro Murine Adipocyte Macrophage Co-Culture Model
por: De Boer, Anna A., et al.
Publicado: (2014)

Staphylococcus aureus controls eicosanoid and specialized pro‐resolving mediator production via lipoteichoic acid
por: Miek, Laura, et al.
Publicado: (2022)

SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators
por: Hachem, Mayssa
Publicado: (2021)

Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury
por: Yin, Ping, et al.
Publicado: (2018)

Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling
por: Díaz del Campo, Lucía Serrano, et al.
Publicado: (2022)

Specialized Pro-Resolving Lipid Mediators: Endogenous Roles and Pharmacological Activities in Infections
por: Rasquel-Oliveira, Fernanda S., et al.
Publicado: (2023)

Impact of the Co-Administration of N-3 Fatty Acids and Olive Oil Components in Preclinical Nonalcoholic Fatty Liver Disease Models: A Mechanistic View
por: Valenzuela, Rodrigo, et al.
Publicado: (2020)

Remodeling of lipid bodies by docosahexaenoic acid in activated microglial cells
por: Tremblay, Marie-Eve, et al.
Publicado: (2016)

Effects of dietary Docosahexaenoic, training and acute exercise on lipid mediators
por: Capó, X., et al.
Publicado: (2016)

Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response
por: Regidor, Pedro-Antonio, et al.
Publicado: (2020)

Treatment with maresin 1, a docosahexaenoic acid-derived pro-resolution lipid, protects skin from inflammation and oxidative stress caused by UVB irradiation
por: Cezar, Talita L. C., et al.
Publicado: (2019)

Lipids in Liver Failure Syndromes: A Focus on Eicosanoids, Specialized Pro-Resolving Lipid Mediators and Lysophospholipids
por: Artru, Florent, et al.
Publicado: (2022)

Inflammatory and Pro-resolving Lipids in Trypanosomatid Infections: A Key to Understanding Parasite Control
por: López-Muñoz, Rodrigo A., et al.
Publicado: (2018)

Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications
por: Valente, Mariarosaria, et al.
Publicado: (2022)

Metabonomics Reveals Drastic Changes in Anti-Inflammatory/Pro-Resolving Polyunsaturated Fatty Acids-Derived Lipid Mediators in Leprosy Disease
por: Amaral, Julio J., et al.
Publicado: (2013)

An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
por: Fredman, Gabrielle, et al.
Publicado: (2016)

In Vivo Availability of Pro-Resolving Lipid Mediators in Oxazolone Induced Dermal Inflammation in the Mouse
por: Homann, Julia, et al.
Publicado: (2015)

Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development
por: Yang, Ailin, et al.
Publicado: (2021)

Sex differences in specialized pro-resolving lipid mediators and their receptors in abdominal aortic aneurysms
por: Filiberto, Amanda C., et al.
Publicado: (2023)

Pro resolving inflammatory effects of the lipid mediators of omega 3 fatty acids and its implication in SARS COVID-19
por: Regidor, Pedro-Antonio, et al.
Publicado: (2020)

CCL2 Inhibition of Pro-Resolving Mediators Potentiates Neuroinflammation in Astrocytes
por: Gutiérrez, Irene L., et al.
Publicado: (2022)

Cell-Type-Specific Gene Regulatory Networks of Pro-Inflammatory and Pro-Resolving Lipid Mediator Biosynthesis in the Immune System
por: Hoch, Matti, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_308d5ptaau6393h33trcqgifgo